menu
    • menu

    Company profile for BioInvent

    NEW Drugs in Dev: 11
    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Together we can improve the quality of life

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Based on its insights in immunology, cancer biology and antibody biology, BioInvent aims to develop cancer immunotherapies to improve the quality of life for cancer patients. BioInvent’s strategy is to leverage its expertise in antibodies and cancer biology to develop immuno-oncology drugs that significantly improve the treatment of cancer diseases and prolong cancer patients' lives. This is accomplished through collaboratio...
    Based on its insights in immunology, cancer biology and antibody biology, BioInvent aims to develop cancer immunotherapies to improve the quality of life for cancer patients. BioInvent’s strategy is to leverage its expertise in antibodies and cancer biology to develop immuno-oncology drugs that significantly improve the treatment of cancer diseases and prolong cancer patients' lives. This is accomplished through collaborations with large pharmaceutical companies, academic research groups, networks of clinical specialists and research foundations.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    BioInventSweden Flag
    Country
    Country
    Sweden
    Address
    Address
    Ideon Science Park SE-223 70 Lund
    Telephone
    Telephone
    +46 (0)46-286 85 50
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.bioinvent.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/bioinvent-international-ab
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/hashtag/bioinvent?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    IMCAS World Congress

    IMCAS World Congress

    Not Confirmed

    envelop Contact Supplier

    IMCAS World Congress

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Bioinvent Reveals Positive Phase 2A Results For BI-1808
    Bioinvent Reveals Positive Phase 2A Results For BI-1808

    05 Jan 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-01-05/bioinvent-reports-promising-data-from-ongoing-phase-2a-study-for-bi-1808-with-keytruda-r-pembroliz

    PHARMIWEB
    05 Jan 2026
    Share Share
    BioInvent To Participate In Upcoming Investor Conference
    BioInvent To Participate In Upcoming Investor Conference

    18 Dec 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-12-18/bioinvent-to-participate-in-upcoming-investor-conference

    PHARMIWEB
    18 Dec 2025
    Share Share
    Bioinvent Unveils Strong Phase 2A Data For BI-1206, Combo In NHL
    Bioinvent Unveils Strong Phase 2A Data For BI-1206, Combo In NHL

    08 Dec 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-12-08/bioinvent-presents-impressive-response-data-from-ongoing-phase-2a-trial-of-triple-combination-bi-120

    PHARMIWEB
    08 Dec 2025
    Share Share
    Bioinvent Unveils Positive Phase 2A BI-1808 Monotherapy Results
    Bioinvent Unveils Positive Phase 2A BI-1808 Monotherapy Results

    07 Dec 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-12-07/bioinvent-presents-promising-early-phase-2a-bi-1808-monotherapy-data-in-ctcl-at-ash-2025

    PHARMIWEB
    07 Dec 2025
    Share Share
    BioInvent's BI-1607: Preclinical, Phase 1 Data in HER2+ Tumors
    BioInvent's BI-1607: Preclinical, Phase 1 Data in HER2+ Tumors

    18 Nov 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-11-18/bioinvent-announces-publication-of-preclinical-and-early-phase-1-data-for-bi-1607-in-her2-positive-a

    PHARMIWEB
    18 Nov 2025
    Share Share
    Bioinvent's BI?1808 Receives EMA Orphan Drug Designation
    Bioinvent's BI?1808 Receives EMA Orphan Drug Designation

    17 Nov 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-11-17/ema-positive-opinion-for-orphan-drug-designation-to-bioinvents-bi-1808-for-the-treatment-of-cutaneo

    PHARMIWEB
    17 Nov 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Contact BioInvent and get a quotation

    BioInvent is a supplier offers 1 products (APIs, Excipients or Intermediates).

    Find a price of MONOCLONAL ANTIBODY PRODUCTION bulk offered by BioInvent

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search